Persson A, Troein M, Lundin S, Midlöv P, Lenander C
Center for Primary Health Care Research, Department of Clinical Sciences Malmö, Lund University, Box 50332, SE-20213 Malmö, Sweden.
Department of Arts and Cultural Sciences, Lund University, LUX, Helgonavägen 3, SE-22100 Lund, Sweden.
Explor Res Clin Soc Pharm. 2024 Feb 14;13:100421. doi: 10.1016/j.rcsop.2024.100421. eCollection 2024 Mar.
The problem with substandard and falsified (SF) medical products may grow in high-income countries when e-commerce of medicines increases. Unauthorized websites offer medicines of insufficient quality. This underscores the importance of evaluating how the problem with SF medical products can be prevented from escalating. However, little is known about what knowledge and experience professionals working primarily with medicines have about the phenomenon.
This study was conducted to explore purposively selected pharmacists' experience and knowledge about SF medical products.
Twelve individual interviews were conducted with purposively selected pharmacists between May 2021 and September 2021. An interview guide was used with specific questions about e-commerce, which focused on exploring pharmacists' experience and knowledge about SF medical products. The interviews lasted, on average, 49 min and were analyzed using inductive qualitative content analysis.
A main theme 'Pharmacists as guardians of safe medicines' emerged. This theme consisted of three categories pinpointing 'risk factors', 'protective factors', and 'opportunities for improvement' regarding SF medical products. Findings suggest that pharmacists can play a role in preventing the problem with SF medical products from escalating. Participants emphasized they were in this line of work to help patients and increase patient safety.
Pharmacists have the opportunity to empower the public with knowledge about SF medical products since they discuss medicines with many people every day. Awareness of risk factors for SF medical products enables pharmacists to guide patients to avoid risky purchases from unauthorized websites. To do this, better communication, and cooperation with patients and other healthcare professionals are needed.
随着药品电子商务的增加,高收入国家中不合格和伪造(SF)医疗产品的问题可能会加剧。未经授权的网站提供质量不佳的药品。这凸显了评估如何防止SF医疗产品问题升级的重要性。然而,对于主要从事药品工作的专业人员对这一现象的了解和经验知之甚少。
本研究旨在探索有目的地挑选的药剂师对SF医疗产品的经验和知识。
在2021年5月至2021年9月期间,对有目的地挑选的药剂师进行了12次个人访谈。使用了一份访谈指南,其中包含关于电子商务的具体问题,重点是探索药剂师对SF医疗产品的经验和知识。访谈平均持续49分钟,并采用归纳定性内容分析法进行分析。
出现了一个主要主题“药剂师作为安全药品的守护者”。这个主题由三类组成,分别指出了关于SF医疗产品的“风险因素”、“保护因素”和“改进机会”。研究结果表明,药剂师可以在防止SF医疗产品问题升级方面发挥作用。参与者强调他们从事这一工作是为了帮助患者并提高患者安全性。
药剂师有机会通过向公众传授有关SF医疗产品的知识来增强公众的能力,因为他们每天都与许多人讨论药品。了解SF医疗产品的风险因素使药剂师能够指导患者避免从未经授权的网站进行有风险的购买。要做到这一点,需要与患者和其他医疗专业人员进行更好的沟通与合作。